ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2016

Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer.

Huiping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.